Table 2.

Identified biomarkers for each prediction.

Normal versus tumor biomarkers	LN negative versus LN positive biomarkers
SLC39A5, C3orf32, TP73, CD1B, PCDHGA4, PCDHGA11, PCDHGA9, PCDHGA1, PCDHGB1, PCDHGB6, PCDHGA12, PCDHGB3, PCDHGB7, PCDHGA6, PCDHGA8, PCDHGA10, PCDHGA5, PCDHGB4, PCDHGA3, PCDHGA2, PCDHGB2, PCDHGA7, PCDHGB5, C20orf197, SLC16A5, FUT8, SLC15A2, C17orf93, PRAC, OCLN, TMEM144, FGF2, PDX1, CCL1, LILRB5, LCE3D, GPR45, LPO, CGB5	LAT2, TTC13, ARV1, NMT1, DCAKD, GJA1, OR7A17, LOX, KRT19, ZNF655, KRTAP4-4, TAAR5, SEMA3E, HOXD1